Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key, a provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, will participate in the 2024 Virtual Tech Conference Series on June 4-5, presented by Maxim Group and hosted by M-Vest. CEO Mike DePasquale will join a Fireside chat on June 4th from 9:00 to 9:30 a.m. ET. The conference will feature discussions on how emerging growth companies leverage new technologies like AI. Investors can engage with management and submit questions during the event. Maxim Group, a full-service investment bank, will facilitate the conference, focusing on technological impacts on business growth.
BIO-key International (Nasdaq: BKYI), a provider of identity and access management solutions, received a non-compliance notice from Nasdaq on May 22, 2024.
The company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024. This delay is attributed to the ongoing restatement of financial statements for various periods in 2023. The company also remains delinquent in filing its Form 10-K for the period ended December 31, 2023.
BIO-key has until June 17, 2024, to submit a compliance plan to Nasdaq. If accepted, an extension until October 14, 2024, may be granted to regain compliance. The company intends to file the delayed reports soon to meet Nasdaq's listing requirements.
BIO-key International (Nasdaq: BKYI), a provider of Identity and Access Management (IAM) solutions, announced plans to file audited 2023 results and report Q1 2024 results next week. The company will also hold an investor call. Details will be provided once confirmed. BIO-key engaged Bush & Associates CPA on April 23, 2024, as its new independent registered public accounting firm.
BIO-key International, Inc. (NASDAQ: BKYI) has won the Hot Company Multi-Factor Authentication award at the 12th Annual Global InfoSec Awards at #RSAC 2024. The company's IAM platform PortalGuard® offers innovative authentication solutions, including biometric options for maximum security.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.